New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
12:58 EDTDDXSdiaDexus recent weakness brings attractive entry point, says Ladenburg
Ladenburg says the recent weakness in shares of diaDexus presents an attractive entry point into the name. The firm expects fundamentals of the company's Lp-PLA2 franchise to strengthen over the next 6-12 months and it reiterates a Buy rating on the stock with a $1.75 price target.
News For DDXS From The Last 14 Days
Check below for free stories on DDXS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 22, 2014
08:32 EDTDDXSdiaDexus says Chief Business Officer Richey to leave company
diaDexus announced that Michael Richey, chief business officer, will be leaving the company effective September 30. The company has initiated a search for a chief commercial officer. Paul Manners will oversee the company's commercial operations in an interim role until the CCO role is filled. Manners was previously vice president, Global Finance and Marketing at Novartis Diagnostics and also held executive finance and commercial positions within Johnson & Johnsonís pharmaceutical and medical device businesses.
08:32 EDTDDXSdiaDexus names Kenneth Fang as Chief Medical Officer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use